Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IPO round-up: K2M ups IPO target, but Lombard and Quotient aim lower

This article was originally published in Clinica

Executive Summary

Contrary to the trend of medtech companies falling short of their IPO hopes, spinal device specialist K2M has increased the target for its initial public offering. The company said in March that it was hoping to raise $100m – but is now aiming for up to $158m. It said in a filing with the US Securities and Exchange Commission (SEC) that it plans to sell 8.8 million shares at $16-18 each. This total could rise further, with the underwriters having a 30-day option to purchase another 1.3 million shares.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT101530

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel